Literature DB >> 496916

Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein.

A Smith, W T Morgan.   

Abstract

Rat [(59)Fe]haem-(125)I-labelled haemopexin complexes (700pmol/rat) associate rapidly and exclusively with the liver after intravenous injection into anaesthetized rats. The two isotopes exhibit different patterns of accumulation. Liver (125)I-labelled haemopexin is maximum 10min after injection (20+/-4.9pmol/g of liver) and then declines by 2h to the low values (about 3pmol/g of liver) seen after injection of the apoprotein. In contrast, [(59)Fe]haem accumulates in the liver for at least 2h. Haemopexin undergoes no extensive proteolysis during 2h of haem transport as shown by precipitation with acid (98%) and specific antiserum (92%) and by electrophoresis. Moreover, only 1-2% of the dose is located in extrahepatic tissues, and there is no significant urinary excretion of either (125)I or (59)Fe. Hepatic uptake at 10min is saturable, reaching 200pmol of haemopexin/g of liver and 350pmol of haem/g of liver at a dose of 9nmol/rat, whereas uptake of the apoprotein is 3-5% of the dose. This suggests that the interaction of haem-haemopexin with the liver is a specific receptor-mediated process. The complex probably interacts via the protein moiety, since the haem analogues mesohaem and deuterohaem do not affect association of the protein with the liver but the species of haemopexin does. Increasing amounts of protein are associated with the liver 5min after injection in the order: human>rabbit>rat, and haem uptake is consistently increased. For both rat and rabbit haemopexin saturation is reached at the same concentration of protein, i.e. 180-200pmol/g of liver, indicating that the different protein species bind to a common receptor. We propose that haemopexin transports haem to the liver by a specific receptor-mediated process and then returns to the circulation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 496916      PMCID: PMC1161233          DOI: 10.1042/bj1820047

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Organ uptake and plasma transportation kinetics of hemoglobin in rats.

Authors:  L GARBY; J OBARA
Journal:  Blut       Date:  1960-06

2.  Haptoglobin hemoglobin metabolism in rabbits studied with I-131 and Fe59 labelled complexes.

Authors:  E C FRANKLIN; M ORATZ; M A ROTHSCHILD; D ZUCKER-FRANKLIN
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

3.  Studies on hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man.

Authors:  L GARBY; W D NOYES
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

4.  The life span of red cells in the rat and the mouse as determined by labeling with DFP32 in vivo.

Authors:  L M VAN PUTTEN
Journal:  Blood       Date:  1958-08       Impact factor: 22.113

5.  Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-l-iduronidase, by cultured human fibroblasts.

Authors:  G N Sando; E F Neufeld
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

6.  The use of wheat-germ lectin-Sepharose for the purification of human haemopexin.

Authors:  P Vretblad; R Hjorth
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

7.  Uptake and degradation of 125I-labelled asialo-fetuin by isolated rat hepatocytes.

Authors:  H Tolleshaug; T Berg; M Nilsson; K R Norum
Journal:  Biochim Biophys Acta       Date:  1977-08-25

8.  Transport of heme by hemopexin to the liver: evidence for receptor-mediated uptake.

Authors:  A Smith; W T Morgan
Journal:  Biochem Biophys Res Commun       Date:  1978-09-14       Impact factor: 3.575

9.  Transfer of heme from heme-albumin to hemopexin.

Authors:  W T Morgan; H H Liem; R P Sutor; U Muller-Ebergard
Journal:  Biochim Biophys Acta       Date:  1976-09-24

10.  Binding and uptake of transcobalamin II by human fibroblasts.

Authors:  P Youngdahl-Turner; L E Rosenberg; R H Allen
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

View more
  44 in total

1.  Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis.

Authors:  Naoki Fujita; Mamoru Nakanishi; Jun Mukai; Yuuji Naito; Takafumi Ichida; Masahiko Kaito; Toshikazu Yoshikawa; Yoshiyuki Takei
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

2.  Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin.

Authors:  Zhantao Yang; John D Philips; Raymond T Doty; Pablo Giraudi; J Donald Ostrow; Claudio Tiribelli; Ann Smith; Janis L Abkowitz
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

3.  The murine haemopexin receptor. Evidence that the haemopexin-binding site resides on a 20 kDa subunit and that receptor recycling is regulated by protein kinase C.

Authors:  A Smith; S M Farooqui; W T Morgan
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

4.  Intracellular distribution of haem after uptake by different receptors. Haem-haemopexin and haem-asialo-haemopexin.

Authors:  A Smith
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

5.  Structure of the human hemopexin gene and evidence for intron-mediated evolution.

Authors:  F Altruda; V Poli; G Restagno; L Silengo
Journal:  J Mol Evol       Date:  1988       Impact factor: 2.395

6.  Metal ions and electrolytes regulate the dissociation of heme from human hemopexin at physiological pH.

Authors:  Marcia R Mauk; A Grant Mauk
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

7.  Further characterization of structural determinants of rabbit hemopexin function.

Authors:  P Muster; F Tatum; A Smith; W T Morgan
Journal:  J Protein Chem       Date:  1991-02

8.  Structure of human hemopexin: O-glycosyl and N-glycosyl sites and unusual clustering of tryptophan residues.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

Review 10.  Heme degradation and vascular injury.

Authors:  John D Belcher; Joan D Beckman; Gyorgy Balla; Jozsef Balla; Gregory Vercellotti
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.